Accepted
at 2:31 a.m. Jan, 22, 2024
by
Willybum
Author:
amanda.j.naylor
Type of change:
Updated content
Rationale for change
There are some attendings who may allow for the use of sugammadex in ESRD/CKD patients. Evidence is currently unavailable to demonstrate either safety or harm.
Before
After
Extra
Extra
Extra
Extra
Text
Personal Notes
Empty field
Missed Questions
Empty field
Textbook
Additional Resources
Empty field
CA-1